accession,name,description,Study Disease/Focus,Study Design,Study Markerset,Parent study,Study Molecular Data Type,Study Content,Ancestry (computed),NIH Institute,Study Consent,Release Date,Embargo Release Date,Related Terms
"phs000007.v30.p11","Framingham Cohort","Startup of Framingham Heart Study. Cardiovascular disease (CVD) is the leading cause of death and serious illness in the United States. In 1948, the Framingham Heart Study (FHS) --  under the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institute, NHLBI) -- embarked on a novel and","Cardiovascular Diseases","Prospective Longitudinal Cohort","HuEx-1_0-st, custom_probe_set, Affymetrix_50K, Affymetrix_100K, Genome-Wide_Human_SNP_Array_5.0, LegacySet, HapMap_phaseII, CVDSNP55v1_A, exome_vcf_grc37, HumanOmni5-4v1_B, target_markerset_grc36, SNP-PCR, HumanMethylation450, WES_markerset_grc36, WGS_markerset_grc36, FHSOmni_Axiom_PLINK_Markerset, HumanExome-12v1_CHARGE-ExomeChip-v6, 1000G_ref_panel, exome_vcf_ESP6800, WGS_markerset_grc37, WES_markerset_grc37, HRC1_ref_panel","Not Applicable","Not Provided","434 phenotype datasets, 61988 variables, 1292 documents, 3029 analyses, 27 molecular datasets, 15154 subjects, 51800 samples, 8 sub-studies","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000209.v13.p3","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","MESA The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and  the risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers","Cardiovascular Diseases","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, CVDSNP55v1_A, exome_vcf_grc37, HumanExome-12v1-1, exome_vcf_ESP6800","Not Applicable","Not Provided","93 phenotype datasets, 22147 variables, 182 documents, 5 molecular datasets, 9780 subjects, 23922 samples, 3 sub-studies","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000280.v5.p1","Atherosclerosis Risk in Communities (ARIC) Cohort","The Atherosclerosis Risk in Communities (ARIC) Study, sponsored by the National Heart, Lung and Blood Institute (NHLBI), is a prospective epidemiologic study conducted in four U.S. communities. The four  communities are Forsyth County, NC; Jackson, MS; the northwest suburbs of Minneapolis, MN; and Washington County, MD. ARIC is designed to investigate","Cardiovascular Diseases","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, CVDSNP55v1_A, HapMap_Phase3, exome_vcf_grc37, Cardio-Metabo_Chip, 1000G_ref_panel, exome_vcf_ESP6800, WES_markerset_grc37, targeted_region_sequencing, WGS_markerset_grc37, LegacySet, target_markerset_grc37, ExomeChip","Not Applicable","Not Provided","289 phenotype datasets, 18704 variables, 357 documents, 15 molecular datasets, 15678 subjects, 43640 samples, 6 sub-studies","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2013-12-11","2017-09-22","Atherogenesis; Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System"
"phs000285.v3.p2","CARDIA Cohort","CARDIA is a study examining the etiology and natural history of cardiovascular disease beginning in young adulthood. In 1985-1986, a cohort of 5115 healthy black and white men and  women aged 18-30 years were selected to have approximately the same number of people in subgroups of age (18-24 and 25-30), sex, race, and education","Cardiovascular Diseases","Prospective Longitudinal Cohort","iSELECT_HG18, Genome-Wide_Human_SNP_Array_6.0, 1000G_ref_panel, exome_vcf_grc37, custom_PCR_marker_set, exome_vcf_ESP6800","Not Applicable","Not Provided","322 phenotype datasets, 9364 variables, 115 documents, 7 molecular datasets,  SRA, 3622 subjects, 13539 samples, 4 sub-studies","European (148), African (9), African American (555), Hispanic1 (6), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension"
"phs000286.v5.p1","Jackson Heart Study (JHS) Cohort","The Jackson Heart Study (JHS) is a large, community-based, observational study whose participants were recruited from urban and rural areas of the three counties (Hinds, Madison and Rankin) that  make up the Jackson Miss, metropolitan statistical area (MSA). Participants were enrolled from each of 4 recruitment pools: random, 17%; volunteer","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55v1_A, Genome-Wide_Human_SNP_Array_6.0, Human1Mv1_C, exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","Not Provided","65 phenotype datasets, 4160 variables, 2 documents, 8 molecular datasets, 3602 subjects, 8876 samples, 4 sub-studies","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2016-07-13","2017-07-13","Arrhythmia; Arrhythmia, Cardiac; Arrhythmias; Arrhythmias, Cardiac; Arrythmia; Cardiac Arrhythmias"
"phs000287.v6.p1","Cardiovascular Health Study (CHS) Cohort","Objectives The Cardiovascular Health Study (CHS) is a study of risk factors for development and progression of CHD and stroke in people aged 65 years and older. The objectives  of the Cardiovascular Health Study are to: 1) quantify associations of conventional and hypothesized risk factors with CHD and stroke; 2) assess the","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55v1_A, HumanCNV370-Duo_v1, exome_vcf_grc37, custom_PCR_marker_set, HumanOmni1-Quad_v1-0_B, exome_vcf_ESP6800, targeted_region_sequencing, WGS_markerset_grc37, WES_markerset_grc37, Cardio-Metabo_Chip, HumanExome-12v1","Not Applicable","Not Provided","56 phenotype datasets, 14718 variables, 22 documents, 11 molecular datasets, 5609 subjects, 16192 samples, 5 sub-studies","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Aging, Biological; Biological Aging; AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris"
"phs000703.v1.p1","CATHeterization GENetics (CATHGEN)","The CATHGEN biorepository consists of biological samples collected on 9334 sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review  Board informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the","Coronary Disease","Cross-Sectional","HumanHT-12_v3, HumanOmni1-Quad_v1-0_C","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 3 molecular datasets, 3304 subjects, 3306 samples, 2 sub-studies","","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000810.v1.p1","Hispanic Community Health Study /Study of Latinos (HCHS/SOL)","The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development  of disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos. The study is sponsored by the National Heart","Cardiovascular Diseases","Prospective Longitudinal Cohort","Cardio-Metabo_Chip, SoL_HCHS_Custom_15041502_B3_RefStrand","Not Applicable","Not Provided","3 phenotype datasets, 282 variables, 2 molecular datasets, 12895 subjects, 25746 samples, 2 sub-studies","","NHLBI","HMB-NPU --- Health/medical/biomedical (npu) , HMB --- Health/medical/biomedical","2015-12-07","2016-12-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001194.v2.p2","Pediatric Cardiac Genomics Consortium (PCGC) Study","Multi-center, prospective observational cohort study of individuals with congenital heart defects (CHD). Phenotypic data and source DNA derived from 10,000 probands, parents, and families of interest are being collected  to investigate relationships between genetic factors and phenotypic and clinical outcomes in patients with CHD. The PCGC Cohort is utilized in the","Heart Defects, Congenital","Prospective Longitudinal Cohort","HumanOmni1-Quad_v1-0_B, HumanOmni25-8v1, HumanOmni2.5-8v1_A, HumanOmni2.5-8v1.1","Not Applicable","Not Provided","20 phenotype datasets, 435 variables, 2 molecular datasets, 9463 subjects, 11829 samples, 1 sub-studies","","NHLBI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2018-09-14","2017-11-09","Abnormalities, Heart; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Cardiac abnormalities; Cardiac abnormality"
"phs001238.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target  organ complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Hypertension","Prospective Longitudinal Cohort","Human1M-Duov3_H, Genome-Wide_Human_SNP_Array_6_0, Human660W-Quad_v1_H, Human1M-Duov3_H, Genome-Wide_Human_SNP_Array_6_0","Not Applicable","Not Provided","39 phenotype datasets, 1118 variables, 1 documents, 1 molecular datasets, 3462 subjects, 3039 samples, 1 sub-studies","","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","2018-08-08","2017-09-08","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"
"phs000128.v3.p3","GAW16 Framingham and Simulated Data","Important links to apply for individual-level data 1. Genetic Analysis Workshop 2. Instructions to Request Authorized Access 3. Data Use Certification Requirements (DUC) 4. Apply here for controlled access  to individual level data 5. Research Use Statement Questions regarding GAW16 should be directed to Vanessa Olmo at vanessa@business-endeavors.com","Coronary Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","207 phenotype datasets, 6582 variables, 6 documents, 2 molecular datasets, 14275 subjects, 7096 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds)","2010-07-28","2008-10-19","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000221.v1.p1","NHLBI Family Heart Study (FamHS)","The Family Heart Study (FamHS) was funded by the National Heart, Lung, and Blood Institute (NHLBI). It was begun in 1992 with the ascertainment of 1,200 families, half randomly  sampled, and half selected because of an excess of coronary heart disease (CHD) or risk factor abnormalities as compared with age- and sex-specific","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","99 analyses","","NHLBI","GRU --- General research use","2011-06-21","","Atherogenesis; CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases"
"phs000279.v2.p1","NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Myocardial Infarction","Prospective Longitudinal Cohort","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 30 variables, 2 molecular datasets,  SRA, 736 subjects, 727 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2013-10-25","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000292.v1.p1","GENEVA Genetics of Early Onset Stroke (GEOS) Study","The Genetics of Early Onset Stroke (GEOS) Study is a population-based case-control study designed to identify genes associated with early-onset ischemic stroke and to characterize interactions of identified stroke  genes and/or SNPs with environmental risk factors such as smoking and oral contraceptive use. The GEOS study consists of 921 ischemic stroke cases","Stroke","Case-Control","HumanOmni1-Quad_v1-0_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 33 variables, 4 documents, 3 molecular datasets, 1862 subjects, 1949 samples","European (990), African (34), East Asian (9), African American (723), Hispanic1 (10), Hispanic2 (13), Other Asian or Pacific Islander (6), South Asian (16), Other (16)","NHGRI","STROKE --- Genetic studies of stroke , MEDCOND --- Studies of genes for medical conditions","2010-08-06","2011-08-06","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs000294.v1.p1","STAMPEED: Myocardial Infarction Genetics Consortium (MIGen)","Myocardial infarction (MI) is a common complex disease and the leading cause of death and disability worldwide. The genetic basis of this disease is largely unknown. It has been  thought that early-onset MI events would have a substantially greater heritability, thus making DNA collections with younger individuals desirable","Myocardial Infarction","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 6042 subjects, 6042 samples","European (5943), African (3), African American (35), Hispanic1 (9), Hispanic2 (20), Other Asian or Pacific Islander (3), South Asian (9), Other (20)","NHLBI","GRU --- General research use","2010-08-24","2010-08-24","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000297.v1.p1","eMERGE Network Study of Resistant Hypertension","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of five participating sites (Group Health Seattle, Marshfield Clinic, Mayo Clinic, Northwestern University, and Vanderbilt University) funded by  the NHGRI to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association","Hypertension","Case-Control","Human1M-Duov3_B, Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 5281 subjects, 5491 samples","European (4097), African (26), East Asian (19), African American (1057), Hispanic1 (25), Hispanic2 (24), Other Asian or Pacific Islander (9), South Asian (8), Other (7)","NHGRI","HR_GHS --- Health research - group health seattle , AGING_GHS --- Dementia or aging - group health seattle , HR_MC --- Health research - marshfield clinic , HR_VU --- Health research - vanderbilt u , HR_MYO --- Health research - mayo clinic , HR_NWU --- Health research - northwestern u","2012-09-26","2013-09-26","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure"
"phs000313.v4.p2","SardiNIA Medical Sequencing Discovery Project","The SardiNIA Medical Sequencing Discovery Project studies the genetics of blood lipid levels and personality in a Sardinian population cohort. The project has generated draft genome sequences for approximately  2,000 individuals using whole genome shotgun sequencing. The draft sequences will allow investigators to evaluate the contribution of common and rare","Cardiovascular Diseases","Family/Twin/Trios","Not Provided","Not Applicable","WGS","5 phenotype datasets, 24 variables,  SRA, 2105 subjects, 2077 samples","","NIA","GRU-IRB --- General research use (irb)","2017-12-05","2011-10-20","Behavior and Behavior Mechanisms"
"phs000327.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Stroke","Family/Twin/Trios","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 44 variables, 2 molecular datasets,  SRA, 94 subjects, 94 samples","","NHLBI","DS-STK-IRB-RD --- Disease specific (stroke and related disorders)","2013-03-25","2013-06-25","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs000338.v1.p1","National Institute on Aging (NIA) SardiNIA Study","Sardinia is the second largest island in the Mediterranean and constitutes a genetically isolated founder population. This population has aided in the identification of genes involved in several Mendelian  disorders and is attractive for genetic studies due to its organization in long-established settlements that developed from an initial group of","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","98 analyses","","NIA","GRU --- General research use","2011-04-26","","Acceptance Process; Acceptance Processes; Process, Acceptance; Processes, Acceptance; Circulating Lipoproteins; Lipoprotein"
"phs000343.v3.p1","The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention    Stroke Prevention (VISP) trial","The VISP trial (PI Jim Toole, M.D., Wake Forest University School of Medicine) was a multi-center, double-blind, randomized, controlled clinical trial that enrolled patients aged 35 or older with  Hcy levels above the 25th percentile at screening and a non-disabling cerebral infarction (NDCI) within 120 days of randomization [Toole, 2002]. The","Stroke","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","39 phenotype datasets, 1918 variables, 50 documents, 2 molecular datasets, 2164 subjects, 2177 samples","European (1720), African (16), East Asian (18), African American (246), Hispanic1 (12), Hispanic2 (54), Other Asian or Pacific Islander (7), South Asian (16), Other (11)","NHGRI","SR --- Stroke research","2013-06-11","2014-06-11","CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary"
"phs000423.v1.p1","GWAS for Early Onset Coronary Disease (ADVANCE)","ADVANCE (Atherosclerotic Disease, VAscular functioN, and genetiC Epidemiology) is a large epidemiological study of genetic and non-genetic determinants of coronary artery disease (CAD) that started in 2000 as a  collaborative effort between researchers at Stanford University and Kaiser Permanente of Northern California. The overarching goal of the study is to","Coronary Disease","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","NPU --- Non profit research use","2012-03-09","","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000442.v1.p1","Drug Resistant Hypertension in African Americans' Exome","Resistant hypertension is defined as blood pressure that remains above goal in spite of the concurrent use of 3 antihypertensive agents of different classes or the concurrent use of  4 or more antihypertensive agents regardless of control. Its diagnosis is important for the identification of patients who are at high risk of having","Hypertension","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 91 subjects, 91 samples","","NHLBI","GRU --- General research use","2012-04-12","2013-04-12","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure"
"phs000456.v1.p1","Risk Assessment of Cerebrovascular Events (RACE) Study","This study includes 1,220 cases with young onset stroke (stroke before age 60 years) who are participants of the larger RACE study. Risk Assessment of Cerebrovascular Events (RACE) is  an on-going existing case-control study of stroke now involving over 5000 imaging confirmed cases of stroke and 5000 controls, recruited from seven","Stroke","Case-Control","Human660W-Quad_v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 39 variables, 3 documents, 2 molecular datasets, 2627 subjects, 2632 samples","European (4), African American (4), Hispanic1 (14), Other Asian or Pacific Islander (2), South Asian (2427), Other (42)","NHGRI","GRU --- General research use","2012-05-08","2013-05-08","Anterior Cerebral Circulation Infarction; Infarction, Anterior Cerebral Circulation; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents"
"phs000514.v1.p1","Identification of Genes Involved in Familial Coronary Artery Disease","Studying families with multiple cases of coronary artery disease (CAD) or with early onset CAD in order to identify new genes involved in CAD in an autosomal dominant manner.  After identifying these genes in families that pass on CAD in Mendelian inheritance, we want to pursue their role in the pathogenesis of CAD and","Coronary Artery Disease","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 19 subjects, 19 samples","","NHGRI","GRU --- General research use","2012-10-25","2012-10-25","Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery"
"phs000546.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Stroke","Case-Control","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 36 variables, 2 molecular datasets, 75 subjects, 75 samples","","NHLBI","DS-STK-IRB-RD --- NULL","2013-07-10","2013-10-10","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000551.v1.p1","Gene expression in CAD","Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n  250) after their index catheterization and age-, sex-, and race-matched controls (n 250) who were free of death/MI 2 years after cardiac","Cardiovascular Diseases","Case-Control","Affy_expression_Human_Genome_U133_Plus2_0","Not Applicable","mRNA Expression (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 594 subjects, 638 samples","","NIGMS","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2012-11-19","2013-05-19","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000580.v1.p1","PAGE: CALiCo: Strong Heart Study (SHS)","The SHS is a study of cardiovascular disease and its risk factors among American Indian men and women. Using standardized methodology, it was designed to estimate cardiovascular disease mortality  and morbidity and the prevalence of known and suspected cardiovascular disease risk factors and to assess the significance of these risk factors in a","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 analyses","","NHGRI","HMB --- Health/medical/biomedical","2013-06-12","","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000581.v1.p1","NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Cardiomyopathy, Dilated","Case Set","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 49 subjects, 48 samples","","NHLBI","DS-FDC --- Disease specific (familial dilated cardiomyopathy)","2013-06-11","2013-09-11","1As, Dilated cardiomyopathy; CARDIOMYOPATHY, CONGESTIVE; CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 1; CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; CARDIOMYOPATHY, IDIOPATHIC DILATED; CDCD1"
"phs000585.v2.p1","International Consortium for Blood Pressure (ICBP)","The ICBP consortium is an international effort to investigate blood-pressure genetics. The consortium was formed by two parent consortia, the CHARGE-BP consortium (Cohorts for Heart and Aging Research in  Genomic Epidemiology - blood pressure) and the GBPGEN consortium (Global Blood Pressure Genetics Consortium). In 2011 we performed genome-wide","Hypertension","Metagenomics","Not Provided","Not Applicable","Not Provided","6 analyses","","NHLBI","GRU-IRB --- General research use (irb)","2016-10-26","2016-10-26","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic; Arterial hypertension"
"phs000606.v1.p1","HIT after Cardiac Bypass","The purpose of this study is to determine how often heart surgery patients who receive heparin develop an immune response (heparin-induced thrombocytopenia) that leads to clots forming in different  parts of the body. These clots usually occur in the legs (deep venous thrombosis or DVT) or lungs (pulmonary embolism or PE) or cause heart attacks","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","11 phenotype datasets, 626 variables, 14 documents, 1051 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-16","2018-03-16","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000649.v1.p1","Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)","This is a prospective, multicenter, randomized, open-label, parallel-group study to evaluate pharmacogenomic responses to antihypertensives. The primary aim of this study is to identify the genetic determinants of antihypertensive  and adverse metabolic responses focused on two preferred and pharmacodynamically contrasting drugs, a beta-blocker (atenolol) and a thiazide diuretic","Hypertension","Prospective Longitudinal Cohort","HapMap_Phase3","Not Applicable","SNP Genotypes (imputed)","4 phenotype datasets, 81 variables, 2 analyses, 1 molecular datasets, 230 subjects, 228 samples","European (219), East Asian (2), Hispanic2 (4), Other Asian or Pacific Islander (2), South Asian (1)","NIGMS","PEAR --- All pear patients","2016-04-01","2016-04-01","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure"
"phs000758.v1.p1","Family Genomics of Congenital Heart Defects","The study identified the causal mutation in a five-generation pedigree harboring a cardiac septal defect. The inheritance pattern is consistent with an autosomal dominant mutation with high penetrance. We  performed whole-genome sequencing (Complete Genomics) on 21 individuals in the pedigree, of which 11 individuals are affected. We identified a single","Heart Septal Defects","Family/Twin/Trios","Mastervar_tsv","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 28 subjects, 21 samples","","NHLBI","HMB --- Health/medical/biomedical","2014-10-07","2015-10-07","Abnormality of the cardiac septa; Cardiac Septal Defects; Congenital cardiac septal defect; Congenital heart defects, septal; Congenital septal defects; Defect, Heart Septal"
"phs000781.v1.p1","Children's Hospital of Philadelphia: GWAS of Left-Sided Cardiac Defects","This is a family-based genome-wide association study of congenital left-sided cardiac lesions (LSLs). Cases with LSLs and their parents were recruited from the Cardiac Center at The Children's Hospital  of Philadelphia between 1997 and 2010. The discovery dataset included 405 LSL case-parent triads. DNA was extracted from blood or saliva samples from","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","","","NHLBI","","","","Abnormalities, Heart; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Cardiac abnormalities; Cardiac abnormality"
"phs000814.v1.p1","MIGen_ExS: Italian Atherosclerosis Thrombosis and Vascular Biology","Italian Atherosclerosis Thrombosis and Vascular Biology study is a prospective, nationwide, case-control study involving 125 coronary care units in Italy. The cases were patients who were hospitalised for a  first MI before the age of 45 years and underwent coronary angiography. Acute MI was defined as resting chest pain lasting more than 30 minutes","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 3592 subjects, 3592 samples","","NHLBI","GRU --- General research use","2016-01-21","2016-01-21","Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery"
"phs000881.v1.p1","Children's Hospital of Philadelphia GWAS of Conotruncal Cardiac Defects","This is a family-based genome-wide association study of conotruncal and related cardiac malformations (CTDs). Cases with CTDs and their parents were recruited from the Cardiac Center at The Children's  Hospital of Philadelphia between 1992 and 2010. The discovery dataset included 750 CTD case-parent triads. DNA was extracted from blood or saliva","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","","","","Double Outlet Right Ventricle, Noncommitted VSD; Double outlet right ventricle, noncommitted ventricular septal defect; Abnormalities, Heart; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart"
"phs000883.v1.p1","MIGen_ExS: PROCARDIS","The Precocious Coronary Artery Disease (PROCARDIS) study is an international, multicenter case-control study aimed at discovering the genetic contributors to premature coronary artery disease. All exome sequencing was performed  at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 2054 subjects, 2054 samples","","NHLBI","DS-HTD --- Disease-specific (heart disease)","2016-01-29","2016-01-29","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000902.v1.p1","MIGen_ExS: Regicor","The Registre Gironi del Cor (REGICOR) study developed a nested case-control cohort from the Girona province in Spain in order to study genetic factors associated with the development of  coronary heart disease. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 784 subjects, 784 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-01-21","2016-01-21","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000916.v1.p1","MIGen_ExS: Munich-MI","The Munich-MI study is a case-control cohort study recruited at the German Heart Center in Munich, Germany. It is focused on understanding the genetic contributors to early myocardial-infarction (MI)  in the German population. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 799 subjects, 799 samples","","NHLBI","DS-CVD-NPU --- Disease-specific (cardiovascular disease, npu)","2016-07-28","2016-07-28","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000917.v1.p1","MIGen_ExS: PROMIS","The Pakistan Risk of Myocardial Infarction (PROMIS) study is a retrospective multicenter case-control cohort study of individuals with and without coronary heart disease from Pakistan. Multiple biological samples have  been collected from the participants including DNA, plasma, serum, and whole blood. The goal of the study is to recruit 20,000 cases and 20,000","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 7298 subjects, 7298 samples","","NHLBI","GRU --- General research use","2016-01-26","2016-01-26","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000924.v2.p1","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource","The iPSCORE Resource of human induced pluripotent stem cells (hiPSCs) was created as part of the Next-Gen Consortium funded by the NHLBI. The overarching purpose of the iPSCORE Resource  is to provide a large collection of hiPSCs for use in studying the impact of genetic variation on molecular and physiological phenotypes. This","Heart Diseases","Family/Twin/Trios","RNAseq_probe_set_grc37, RNAseq_gene_transcripts, HumanCoreExome-12v1-1_A, HumanCoreExome-24v1-0_A, HumanMethylation450, MEGA_Consortium_v2_15070954_A2","Not Applicable","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), ChIP-Seq, RNA-Seq, RNA Seq expression levels","5 phenotype datasets, 63 variables, 1 documents, 5 molecular datasets,  SRA, 273 subjects, 1477 samples","European (145), East Asian (21), African American (4), Hispanic1 (3), Hispanic2 (10), Other Asian or Pacific Islander (20), South Asian (6), Other (15)","NHLBI","GRU --- General research use , DS-CMP-MDS --- Disease-specific (cardiomyopathy, mds) , DS-CMP-MD-MDS --- Disease-specific (cardiomyopathy and mitochondrial disease, mds)","","","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Cardiac Disease; Cardiac Diseases"
"phs000925.v1.p1","PAGE: IPM BioMe Biobank","The Institute for Personalized Medicine (IPM) BioMe Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over  70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86","Cardiovascular Diseases","Prospective Longitudinal Cohort","MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 21 variables, 1 molecular datasets, 13067 subjects, 13883 samples","European (308), African (509), East Asian (615), African American (5928), Hispanic1 (2720), Hispanic2 (1044), Other Asian or Pacific Islander (245), South Asian (695), Other (690)","NHGRI","GRU --- General research use","2017-03-29","2017-03-29","Cholesterol, HDL2; HDL cholesterol 2; HDL(2) Cholesterol; HDL2 Cholesterol; High density lipoprotein cholesterol subfraction 2; High density lipoprotein cholesterol, sub-fraction II"
"phs000930.v6.p1","CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology)","GWAS have successfully identified genetic loci associated with a variety of conditions such as type 2 diabetes and coronary disease. The large number of statistical tests required in GWAS  has posed a special challenge because few studies that have DNA and high-quality phenotype data are sufficiently large to provide adequate","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","144 analyses, 1 molecular datasets","","NHLBI","GRU --- General research use","2018-04-03","2017-03-17","Brain Vascular Disorder; Brain Vascular Disorders; CVD - Cerebrovascular disease; Cerebrovascular Disease; Cerebrovascular Diseases; Cerebrovascular lesion"
"phs000956.v3.p1","NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish","The Amish Complex Disease Research Program includes a set of large community-based studies focused largely on cardiometabolic health carried out in the Old Order Amish (OOA) community of Lancaster,  Pennsylvania (http://medschool.umaryland.edu/endocrinology/amish/research-program.asp). The OOA population of Lancaster County, PA immigrated to the","Cardiovascular Diseases","Family/Twin/Trios","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 74 variables, 3 documents, 3 molecular datasets,  SRA, 1123 subjects, 1111 samples","European (1111)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds)","2018-05-17","2018-05-17","Not Provided"
"phs000958.v1.p1","CSER-MedSeq","Whole genome sequencing (WGS) and whole exome sequencing (WES) services are currently available to and being utilized by physicians and their patients in both research and clinical settings, and  recently to anyone in the general public via direct-to-consumer companies. But the widespread availability and use of WGS and WES in the practice of","Cardiomyopathies","Case-Control","HumanOmni2.5-8v1_A, HumanOmni25-8v1","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 22 variables, 3 documents, 2 molecular datasets,  SRA, 100 subjects, 200 samples","","NHGRI","GRU --- General research use","2015-10-21","2015-10-21","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary"
"phs000964.v3.p1","NHLBI TOPMed: The Jackson Heart Study","Since there is a greater prevalence of cardiovascular disease among African Americans, the purpose of the Jackson Heart Study (JHS) is to explore the reasons for this disparity and  to uncover new approaches to reduce it. The JHS is a large, community-based, observational study whose 5306 participants were recruited from among","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 3 documents, 3 molecular datasets,  SRA, 3596 subjects, 3406 samples","African (75), East Asian (1), African American (3314), Hispanic1 (15), Other (1)","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2018-05-18","2018-05-18","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure"
"phs000968.v1.p1","The Cardiopulmonary Effects of Particulate Exposure","The study was initially designed as a longitudinal cohort study of cardiovascular effects of particulate exposure. Participants were boilermaker construction workers who were exposed to particulate matter (PM) component  (e.g. a focus on metal constituents) while performing welding, grinding or cutting work in the welding plants. Participants were followed up","Cardiovascular Disease","Prospective Longitudinal Cohort","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 22 variables, 1 molecular datasets, 75 subjects, 208 samples","","NIEHS","DS-CVD-NPU --- Health/medical/biomedical (irb)","2015-11-19","2016-05-19","Not Provided"
"phs000974.v3.p2","NHLBI TOPMed: Whole Genome Sequencing and Related Phenotypes in the    Framingham Heart Study","The Framingham Heart Study (FHS) is a prospective cohort study of 3 generations of subjects who have been followed up to 65 years to evaluate risk factors for cardiovascular  disease. Its large sample of 15,000 men and women who have been extensively phenotyped with repeated examinations make it ideal for the study of","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 2 documents, 3 molecular datasets,  SRA, 4154 subjects, 4166 samples","European (4145), Hispanic1 (2), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-05-30","2018-05-30","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000990.v1.p1","MIGen_ExS: University of Lubeck","MI cases were recruited from the German MI Family Study and the Angio-Lub study. Controls were recruited from the German MI Family Study and the Angio-Lub study. All exome  sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Illumina's ICE Capture reagent and","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1766 subjects, 1766 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-05-04","2016-05-04","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000993.v3.p2","NHLBI TOPMed: Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation  (AF). The study setting is Group Health, an integrated health care delivery system in Washington State. Only VT cases and early-onset AF cases are","Cardiovascular Disease","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 3 molecular datasets,  SRA, 709 subjects, 711 samples","European (578), East Asian (5), African American (25), Hispanic1 (3), Hispanic2 (5), Other Asian or Pacific Islander (2), South Asian (1), Other (4)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, irb, mds)","2019-01-09","2019-01-09","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001000.v1.p1","MIGen_ExS: U. of Leicester","MI cases were ascertained from two studies: (i) the British Heart Foundation Family Heart Study and (ii) the BRICCS Study. Control subjects were ascertained from the control subjects being  recruited as part of the UK Aneurysm Growth Study (UKAGS). All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 2322 subjects, 2322 samples","","NHLBI","DS-CVD-NPU --- Disease-specific (cardiovascular disease, npu) , GRU-NPU --- General research use (npu)","2016-04-12","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001012.v1.p1","The Diabetes Heart Study (DHS)","The Diabetes Heart Study is a family based study enriched for type 2 diabetes (T2D). The cohort included 1220 self-reported European Americans from 475 families (Bowden et al 2010  Review of Diabetic Studies 7:188-201: PMID: 21409311; Bowden et al 2008 Annals of Human Genetics 72:598-601 PMID: 18460048) and included siblings","Cardiovascular Diseases","Cross-Sectional","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 29 variables, 1 analyses, 1 molecular datasets, 1177 subjects, 1177 samples","European (1176), Hispanic1 (1)","NHLBI","DS-DRC-IRB --- Disease-specific (diabetes and related complications, irb)","2016-11-15","2017-11-15","Calcification, Vascular; Calcifications, Vascular; Calcinoses, Vascular; Calcinosis, Vascular; Vascular Calcification; Vascular Calcifications"
"phs001013.v3.p2","Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation  (AF). The study setting is Group Health, an integrated health care delivery system in Washington State. Background The HVH originated in 1988 with","Cardiovascular Disease","Case-Control","HumanOmniExpress-12v1_H, HumanOmniExpressExome-8v1_A, HumanCNV370-Quadv3_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 38 variables, 5 documents, 1 molecular datasets, 1204 subjects, 1014 samples","European (943), African (1), East Asian (13), African American (24), Hispanic1 (3), Hispanic2 (12), Other Asian or Pacific Islander (8), South Asian (4), Other (6)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, irb, mds)","2018-01-16","2018-01-16","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001058.v1.p1","MIGen_ExS: BioImage Study","The BioImage Study (BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population, NCT00738725), is a prospective, observational study aimed at characterizing subclinical atherosclerosis in  U.S. adults (55 to 80 years old) at risk for clinical atherosclerotic cardiovascular disease (PMID: 25790876). All exome sequencing was performed at","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 503 subjects, 503 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-02-19","2016-02-19","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001101.v1.p1","MIGen_ExS: MDC","The Malmo Diet and Cancer Study (MDCS) is a community-based prospective epidemiologic cohort of 28,449 subjects who were recruited for baseline examination between 1991 and 1996. From this cohort,  6103 subjects were randomly selected to participate in a cardiovascular cohort (MDCSCC), which seeks to investigate risk factors for cardiovascular","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1081 subjects, 1081 samples","","NHLBI","HMB-MDS --- Health/medical/biomedical (mds)","2016-08-10","2016-08-10","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001138.v2.p2","GMKF: Kids First Pediatric Research Program in Congenital Heart Disease","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","WGS","3 phenotype datasets, 10 variables,  SRA, 900 subjects, 890 samples","","NCI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2018-09-14","2018-09-14","Abnormalities, Heart; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Cardiac abnormalities; Cardiac abnormality"
"phs001203.v1.p1","Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task    (STARNET)","STARNET is a genetics of RNA expression study of multiple disease-relevant tissues obtained from living patients with cardiovascular disease. Tissue samples are obtained from blood, atherosclerotic-lesion-free internal mammary artery  (MAM) and atherosclerotic aortic root (AOR), subcutaneous fat (SF), visceral abdominal fat (VAF), skeletal muscle (SKLM), and liver (LIV) during open","Coronary Artery Disease","Case Set","RNAseq_gene_transcripts","Not Applicable","RNA Seq expression levels","3 phenotype datasets, 9 variables, 1 molecular datasets, 566 subjects, 3577 samples","","NHLBI","HMB --- Health/medical/biomedical","2016-12-14","2016-12-14","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs001211.v2.p2","NHLBI TOPMed: Trans-Omics for Precision Medicine Whole Genome Sequencing    Project: ARIC","Participants from the Atherosclerosis Risk in Communities (ARIC) Study, a large population-based longitudinal cohort study, have been included in this Project and whole genome sequencing will be performed to  contribute to analyses of early-onset atrial fibrillation and venous thromboembolism. Additional phenotype and genotype data are available for these","Cardiovascular Diseases","Case-Control","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets,  SRA, 13546 subjects, 13550 samples","European (3375), African (14), African American (224), Hispanic1 (3), Hispanic2 (3)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2019-02-14","2019-02-14","Arrhythmia; Arrhythmia, Cardiac; Arrhythmias; Arrhythmias, Cardiac; Arrythmia; Cardiac Arrhythmias"
"phs001237.v1.p1","NHLBI TOPMed: Women's Health Initiative (WHI)","This is Whole Genome Sequencing data from the TOPMed participation of the Women's Health Initiative. Approximately 11,100 subjects were involved in this study: approximately 1,100 cases of VTE, 4,000  cases of ischemic stroke, 900 cases of hemorrhagic stroke, and 5,100 controls. Summary level phenotypes for the WHI Cohort study participants can be","Stroke","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 15 variables, 2 documents, 1 molecular datasets,  SRA, 11357 subjects, 11640 samples","European (8223), African (46), East Asian (147), African American (1255), Hispanic1 (78), Hispanic2 (193), Other Asian or Pacific Islander (41), Other (17)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2019-01-17","2019-01-17","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs001325.v1.p1","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource - Whole Genome Sequence","The iPSCORE Resource of human induced pluripotent stem cells (hiPSCs) was created as part of the Next-Gen Consortium funded by the NHLBI. The overarching purpose of the iPSCORE Resource  is to provide a large collection of hiPSCs for use in studying the impact of genetic variation on molecular and physiological phenotypes. This","Heart Diseases","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 35 variables, 1 molecular datasets,  SRA, 273 subjects, 273 samples","European (187), African (1), East Asian (21), African American (5), Hispanic1 (4), Hispanic2 (12), Other Asian or Pacific Islander (21), South Asian (6), Other (16)","NHLBI","GRU-NPU --- General research use (npu) , DS-CMP-NPU-MDS --- Disease-specific (cardiomyopathy, npu, mds) , DS-CMP-MD-NPU-MDS --- Disease-specific (cardiomyopathy and mitochondrial disease, npu, mds)","2017-06-06","2017-06-06","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Cardiac Disease; Cardiac Diseases"
"phs001345.v1.p1","NHLBI TOPMed: Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target  organ complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Hypertension","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 1 molecular datasets,  SRA, 1854 subjects, 1266 samples","African (42), African American (1095), Hispanic1 (4), Other (2)","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","","","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"
"phs001368.v1.p1","NHLBI TOPMed: Cardiovascular Health Study","Participants from the Cardiovascular Health Study (CHS), a large population-based longitudinal cohort study (phs000287), have been included in the TOPMed project. Whole genome sequencing will be performed to contribute  to multiple analyses, including cardiovascular disease risk factors, subclinical disease measures, the occurrence of myocardial infarction (MI) and","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets,  SRA, 3622 subjects, 3622 samples","European (56), African (2), African American (10), Hispanic1 (1)","NHLBI","HMB-MDS --- Health/medical/biomedical (mds) , HMB-NPU-MDS --- Health/medical/biomedical (npu, mds) , DS-CVD-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2018-06-13","2018-06-13","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs001394.v1.p1","Hypertension-Insulin Resistance Family Study (HTN-IR)","The HTN-IR Study, funded by NHLBI, was designed to explore genetic contributions to hypertension and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination of the  cohort included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and metabolic","Hypertension","Family/Twin/Trios","HumanOmni1S-8v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 765 subjects, 765 samples","European (14), Hispanic2 (695), Other Asian or Pacific Islander (1), Other (55)","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-specific (cardiovascular, metabolic, and endocrine diseases, irb, npu, mds, gso)","2018-01-03","2018-01-03","Arterial hypertension; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure"
"phs001397.v1.p1","Mexican-American Coronary Artery Disease Study (MACAD)","The MACAD Study, funded by NHLBI, was designed to explore genetic contributions to coronary artery disease and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination  of the cohort included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and","Coronary Artery Disease","Family/Twin/Trios","HumanOmni1S-8v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 821 subjects, 821 samples","European (6), African American (2), Hispanic1 (2), Hispanic2 (780), Other (31)","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-specific (cardiovascular, metabolic, and endocrine diseases, irb, npu, mds, gso)","2018-01-03","2018-01-03","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs001412.v1.p1","NHLBI TOPMed: Diabetes Heart Study (DHS) African American Coronary Artery    Calcification (AA CAC)","The Diabetes Heart Study (DHS) is a family-based study enriched for type 2 diabetes (T2D). The cohort included 1443 European American and African American participants from 564 families with  multiple cases of type 2 diabetes (Bowden et al., 2010. Review of Diabetic Studies 7:188-201. PMID: 21409311). The cohort was recruited between 1998","Cardiovascular Disease","Cross-Sectional","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 54 variables, 2 documents, 1 molecular datasets,  SRA, 405 subjects, 403 samples","African (11), African American (326)","NHLBI","HMB-IRB-COL-NPU --- Health/medical/biomedical (irb, col, npu) , DS-DHD-IRB-COL-NPU --- Disease-specific (diabetes and heart disease, irb, col, npu)","2019-02-14","2019-02-14","Calcification, Vascular; Calcifications, Vascular; Calcinoses, Vascular; Calcinosis, Vascular; Vascular Calcification; Vascular Calcifications"
"phs001672.v1.p1","VA Million Veteran Program (MVP)","MVP is an ongoing prospective cohort study and mega-biobank in the Department of Veterans Affairs Healthcare System designed to study genetic influences on health and disease among veterans.","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","4 analyses","","NHLBI","HMB-MDS --- Health/medical/biomedical (mds)","2018-11-01","2018-11-01","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000090.v5.p1","GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study","This sub-study phs000090 GENEVA ARIC contains genotype data and selected phenotype of subjects available from the phs000090 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can  be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study","Cardiovascular Diseases","Case-Control","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 366 variables, 166 documents, 3 molecular datasets,  SRA, 12771 subjects, 13249 samples","European (9590), African (112), East Asian (1), African American (3003), Hispanic1 (34), Hispanic2 (20), Other Asian or Pacific Islander (1), South Asian (2), Other (8)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2013-12-11","2017-09-22","Atherogenesis; Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System"
"phs000223.v5.p1","PAGE: CALiCo: Atherosclerosis Risk in Communities (ARIC)","This sub-study phs000223 PAGE CALiCo ARIC contains genotype data and selected phenotype of subjects available from the phs000223. Summary level phenotypes for the NHLBI ARIC Cohort study participants can  be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 6 variables, 4 analyses, 1 molecular datasets, 3743 subjects, 3425 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2013-12-11","2017-09-22","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000226.v6.p1","STAMPEED: Cardiovascular Health Study (CHS)","Note: This substudy phs000226 STAMPEED Cardiovascular Health Study contains GWAS data of the subset of the CHS cohort selected for the NHLBI's SNP Typing for Association with Multiple Phenotypes  from Existing Epidemiologic Data (STAMPEED) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 5 variables, 2 documents, 6 analyses, 2 molecular datasets, 4211 subjects, 4792 samples","European (3345), African (48), East Asian (2), African American (763), Hispanic1 (26), Hispanic2 (19), Other (7)","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Aging, Biological; Biological Aging; Brain Vascular Disorder; Brain Vascular Disorders; CVD - Cerebrovascular disease; Cerebrovascular Disease"
"phs000236.v2.p2","PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA)","This sub-study phs000236 PAGE CALiCo CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000236 study. Summary level phenotypes for the NHLBI CARDIA  Cohort study participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (PCR)","1 phenotype datasets, 3 variables, 83 documents, 4 analyses, 1 molecular datasets, 3595 subjects, 3595 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000282.v19.p11","NHLBI Framingham Candidate Gene Association Resource (CARe)","This substudy phs000282 Framingham CARe contains 50K genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association  Resource (CARe) project. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page phs000007","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (Array)","1 molecular datasets, 8556 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000283.v7.p3","NHLBI MESA Candidate Gene Association Resource (CARe)","This substudy phs000283 MESA CARe contains 50k genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association  Resource (CARe) project. Summary level phenotypes for the MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 6354 subjects, 6420 samples","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000301.v5.p1","PAGE: CALiCo: Cardiovascular Health Study (CHS)","Note: This substudy phs000301 PAGE Cardiovascular Health Study contains genotypes on selected SNP loci of the subset of the CHS cohort selected for the NHGRI's Population Architecture using Genomics  and Epidemiology (PAGE) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be viewed at the top","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (PCR)","2 phenotype datasets, 8 variables, 4 analyses, 2 molecular datasets, 5346 subjects, 5346 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris; Cardiac angina; Ischemic heart disease - angina"
"phs000307.v15.p11","NHLBI Framingham Heart Study Allelic Spectrum Project","This substudy phs000307 Framingham Allelic Spectrum Project includes the generation of deep coverage targeted re-sequencing and variant identification for 216 genes in the Framingham Heart Study (FHS) sample collection,  produced as part of NHLBI's Medical Resequencing projects. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 4 variables, 1 molecular datasets,  SRA, 1634 subjects, 1634 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12",""
"phs000309.v3.p2","The CARDIA-GENEVA Study","This sub-study phs000309 GENEVA CARDIA contains genotype and selected phenotype of subjects available from the phs000309 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be  viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 155 variables, 59 documents, 2 molecular datasets, 1926 subjects, 4991 samples","European (1644), East Asian (1), African American (1), Hispanic1 (5), Hispanic2 (12), Other Asian or Pacific Islander (7), Other (5)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension"
"phs000315.v7.p3","WHI GARNET","This substudy phs000315 WHI GARNET contains genotypes generated using Illumina array, produced as part of NHGRI's GARNET project. Summary level phenotypes for the WHI Cohort study participants can be  viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and","Cardiovascular Diseases","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 4983 samples","European (4338), African (13), East Asian (64), African American (273), Hispanic1 (45), Hispanic2 (105), Other Asian or Pacific Islander (36), Other (20)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000342.v18.p11","NHLBI Framingham SNP Health Association Resource (SHARe)","This substudy phs000342 Framingham SHARe contains 100K and 550K genotypes, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. It also contains 4.3 million genotypes produced under  Illumina's Fast Track Genotyping Service. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (Array), SNP Genotypes (imputed), Legacy Genotypes, SNP Genotypes (PCR)","2 phenotype datasets, 8 variables, 2812 analyses, 11 molecular datasets, 10315 subjects, 31682 samples","European (4616), African (3), East Asian (105), African American (269), Hispanic1 (134), Hispanic2 (158), Other Asian or Pacific Islander (22), South Asian (84), Other (62)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000363.v17.p11","NHLBI Framingham SABRe CVD","This substudy phs000363 Framingham SABRe contains immunoassays, gene expression profiling, and microRNA data. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study  page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","miRNA Expression (Array), mRNA Expression (Array)","21 phenotype datasets, 1404 variables, 73 documents, 2 molecular datasets, 7558 subjects, 11329 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000377.v5.p1","NHLBI Cardiovascular Health Study (CHS) Candidate Gene Association    Resource (CARe)","Note: This substudy phs000377 CARe Cardiovascular Health Study contains 50K genotypes from 2,100 candidate genes produced as part of NHLBI's Candidate-Gene Association Resource (CARe) project. Summary level phenotypes for  the Cardiovascular Health Study Cohort study participants can be viewed at the top-level study page phs000287 Cardiovascular Health Study (CHS","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array)","2 phenotype datasets, 7 variables, 1 molecular datasets, 5279 subjects, 5282 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris; Cardiac angina; Ischemic heart disease - angina"
"phs000398.v5.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)","This sub-study phs000398 HeartGO_ARIC contains genotype derived from sequence data and selected phenotype of subjects available from the phs000398 study. Summary level phenotypes for the NHLBI ARIC Cohort study  participants can be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort","Cardiovascular Diseases","Case-Control","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (NGS), WXS, SNP Genotypes (NGS), WXS","2 phenotype datasets, 127 variables, 3 molecular datasets,  SRA, 843 subjects, 843 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2013-12-11","2017-09-22","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000399.v1.p2","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)","This sub-study phs000399 GO-ESP HeartGO_CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000399 study. Summary level phenotypes for the NHLBI CARDIA Cohort  study participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 86 variables, 2 molecular datasets,  SRA, 199 subjects, 199 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000400.v5.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)","Note: This substudy phs000400 GO-ESP Cardiovascular Health Study contains harmonized phenotype data, whole exome sequencing and .vcf data of the subset of the CHS cohort selected for NHLBI's GO-ESP  Exome Sequencing Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at the top-level study page","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (NGS), WXS","3 phenotype datasets, 123 variables, 3 molecular datasets,  SRA, 210 subjects, 211 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000401.v13.p11","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (FHS)","This substudy phs000401 Framingham ESP Heart-GO contains exome sequence data and harmonized phenotype variables, produced as part of NHLBI's GO-ESP project. Summary level phenotypes for the Framingham Cohort study  participants can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 110 variables, 2 molecular datasets,  SRA, 462 subjects, 720 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000402.v3.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (JHS)","This sub-study phs000402 HeartGO JHS contains genotype derived from sequence data and selected phenotype of subjects available from the phs000402 study. Summary level phenotypes for the NHLBI JHS Cohort  study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS","Cardiovascular Diseases","Case-Control","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v5.p1)","SNP Genotypes (NGS), WXS","3 phenotype datasets, 100 variables, 3 molecular datasets,  SRA, 402 subjects, 403 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2016-07-13","2017-07-13","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000403.v3.p3","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 97 variables, 2 molecular datasets,  SRA, 404 subjects, 404 samples","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Brain Ischemias; Brain ischemia; Cerebrovascular ischemia; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies"
"phs000420.v6.p3","NHLBI MESA SHARe","This substudy phs000420 MESA SHARe contains Affy 6.0 genotypes and Infinium HumanExome BeadChip data, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. Summary level phenotypes for  the MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA Cohort. Individual level phenotype data and molecular","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","CNV Genotypes, SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 8388 subjects, 17098 samples","European (2737), African (122), East Asian (773), African American (2648), Hispanic1 (457), Hispanic2 (1354), Other Asian or Pacific Islander (14), South Asian (2), Other (117)","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000498.v3.p1","Jackson Heart Study Allelic Spectrum Project","This sub-study phs000498 JHS Allelic Spectrum Seq contains genotype derived from sequence data and selected phenotype of subjects available from the phs000498 study. Summary level phenotypes for the NHLBI  JHS Cohort study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v5.p1)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 5 variables, 1 molecular datasets,  SRA, 1983 subjects, 1983 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2016-07-13","2017-07-13","Not Provided"
"phs000571.v5.p2","PCGC: Congenital Heart Disease Genetic Network Study","This substudy phs000571 PCGC contains whole exome sequences, targeted sequences, and SNP array data. Summary level phenotypes for the PCGC Cohort study participants can be viewed at the top-level  study page phs001194 PCGC Cohort. Individual level phenotype data and molecular data for all PCGC top-level study and substudies are available by","Heart Defects, Congenital","Prospective Longitudinal Cohort","Not Provided","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Pediatric Cardiac Genetics Consortium (PCGC) Study (phs001194.v2.p2)","AMPLICON, SNP Genotypes (Array), RNA-Seq, WGS, WXS","2 phenotype datasets, 14 variables, 2 molecular datasets,  SRA, 9444 subjects, 11829 samples","European (1438), African (6), East Asian (22), African American (144), Hispanic1 (121), Hispanic2 (134), Other Asian or Pacific Islander (28), South Asian (70), Other (48)","NHLBI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2018-09-14","2017-11-09","Abnormalities, Heart; Abnormality of cardiac morphology; Abnormality of the heart; Abnormality, Heart; Cardiac abnormalities; Cardiac abnormality"
"phs000613.v1.p2","NHLBI CARDIA Candidate Gene Association Resource (CARe)","This sub-study phs000613 CARDIA_CARe contains genotype of subjects available from the phs000613 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be viewed at the top-level  study page phs000285 CARDIA_v3 Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study and sub-study are","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 3299 subjects, 4754 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; Arterial hypertension; BP - High blood pressure; BP+ - Hypertension"
"phs000651.v10.p11","Building on GWAS: the U.S. CHARGE consortium - Sequencing (CHARGE-S): FHS","This substudy phs000651 Framingham CHARGE-S contains whole genome, whole exome, and targeted sequence data, produced as part of NHLBI's CHARGE-S project. Summary level phenotypes for the Framingham Cohort study  participants can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","5 phenotype datasets, 40 variables, 7 molecular datasets,  SRA, 2532 subjects, 2532 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000667.v3.p1","Building on GWAS for NHLBI-Diseases: The U.S. CHARGE Consortium -    Sequencing (CHARGE-S): CHS","Note: This substudy phs000667 CHARGE-S Cardiovascular Health Study contains harmonized phenotype data, whole genome, exome, targeted sequencing data and exome chip data of a subset of the CHS cohort  selected for NHLBI's CHARGE-S CONSORTIUM Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (NGS), WGS, WXS","5 phenotype datasets, 40 variables, 3 molecular datasets,  SRA, 5114 subjects, 7743 samples","European (236), Hispanic2 (1)","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000704.v1.p1","CATHGEN: Identification of Novel Genetic and Metabolomic CV Phenotypes","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board  informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization","Coronary Disease","Cross-Sectional","Not Provided","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 20 variables, 2 documents, 1 molecular datasets, 1327 subjects, 1327 samples","European (944), African (11), East Asian (2), African American (268), Hispanic1 (86), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (6), Other (3)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000705.v1.p1","CATHGEN: Genetic Mediators of Metabolic Cardiovascular Disease Risk","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board  informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization","Coronary Disease","Cross-Sectional","Not Provided","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (Array), mRNA Expression (Array)","2 phenotype datasets, 19 variables, 2 documents, 2 molecular datasets, 1977 subjects, 1979 samples","European (1391), African (18), East Asian (4), African American (398), Hispanic1 (94), Hispanic2 (11), Other Asian or Pacific Islander (3), South Asian (10), Other (2)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000860.v3.p1","MIchigan-CORnell-TEXas (MICORTEX)","This sub-study phs000860 MICORTEX contains genotype and selected phenotype of subjects available from the phs000860 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed  at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and sub","Coronary Disease","Prospective Longitudinal Cohort","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","Legacy Genotypes","1 phenotype datasets, 4 variables, 1 molecular datasets, 7218 subjects, 7218 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2013-12-11","2017-09-22","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000880.v1.p1","Omics in Latinos (Ola) - Genetic Analysis of HCHS/SOL","This sub-study phs000880 HCHS SOL Hispanic Community Health Study contains genotype data and selected phenotype of subjects available from the phs000880. Summary level phenotypes for the NHLBI HCHS SOL  Cohort study participants can be viewed at the top-level study page phs000810 HCHS SOL Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 12437 subjects, 13405 samples","European (1284), African (2), East Asian (1), African American (1092), Hispanic1 (2776), Hispanic2 (6284), Other Asian or Pacific Islander (11), Other (987)","NHLBI","HMB-NPU --- Health/medical/biomedical (npu) , HMB --- Health/medical/biomedical","2015-12-07","2016-12-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001334.v1.p3","Metabolomics of Coronary Heart Disease (CHD) in the WHI","The primary goal of this substudy phs001334 Metabolomics of CHD in WHI study was to analyze the relationship between metabolite profiles and incident coronary heart disease (CHD) in women  using a nested case-control design. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page","Coronary Heart Disease","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","Not Provided","3 phenotype datasets, 746 variables, 1 documents, 2151 subjects","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs001335.v1.p3","NHLBI's BA23 in WHI","This substudy phs001335 Integrative genomics and risk of CHD and related phenotypes in WHI study was to analyze epigenetic markers in blood and to associate these markers with phenotypes  related to coronary heart disease. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200","Coronary Artery Disease","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","Methylation (CpG), miRNA Expression (Array)","2 phenotype datasets, 23 variables, 2 documents, 1 molecular datasets, 2129 subjects, 4256 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Aging, Biological; Biological Aging; Blood Sugar; Glucose, Blood; Sugar, Blood; DAP - Diastolic arterial pressure"
"phs001401.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA): GWAS Studies","This substudy phs001401 GENOA GWAS Studies, contains genome-wide genetic variants on a subset of participants in the GENOA Cohorts. A total of 1385 European American and 1263 African American  participants from GENOA were genotyped on the Affymetrix Genome-Wide Human SNP Array 6.0 array using the protocol outlined by Affymetrix (Affymetrix","Hypertension","Prospective Longitudinal Cohort","Not Provided","Genetic Epidemiology Network of Arteriopathy (GENOA) (phs001238.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 3039 subjects, 3039 samples","European (1507), African (48), African American (1478), Hispanic1 (4), Other (2)","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","2018-08-08","2017-09-08","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"

